CYB 210010
Alternative Names: CYB-210010Latest Information Update: 13 May 2024
At a glance
- Originator Cybin
- Class Antipsychotics; Phenethylamines; Small molecules
- Mechanism of Action Serotonin 5-HT2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Neurological disorders; Psychiatric disorders
Most Recent Events
- 18 Apr 2024 Preclinical trials in Neurological disorders in Canada (PO) before April 2024
- 18 Apr 2024 Preclinical trials in Psychiatric disorders in Canada (PO) before April 2024
- 18 Apr 2024 Pharmacodynamics data from a preclinical trial in Neurological disorders and Psychiatric disorders released by Cybin